Significant association of insulin and proinsulin with clustering of cardiovascular risk factors

Table 3 ANCOVA analysis of PI and risk factors (age and sex are covariate).

Risk factors		N (M/F)	Median (QR)	F	P
Hypertension	Y	149/142	4.24(2.49-6.66)	20.523	0
	N	384/521	3.34(2.02-5.31)
Hyperglycemia	Y	17/22	11.20(7.54-17.52)	78.858	0
	N	516/641	3.43(2.04-5.36)
Obesity	Y	149/227	4.70(2.93-7.46)	70.508	0
	N	382/436	3.13(1.84-4.72)
Visceral obesity	Y	137/214	4.67(3.05-7.56)	69.619	0
	N	395/449	3.13(1.83-4.86)
High CH	Y	85/78	4.72(2.89-7.01)	25.807	0
	N	448/585	3.36(2.02-5.32)
High LDL	Y	72/79	4.35(2.62-6.65)	15.775	0
	N	460/579	3.40(2.04-5.39)
High TG	Y	66/74	5.37(3.63-8.57)	54.298	0
	N	467/589	3.31(1.99-5.30)
Low HDL	Y	258/297	3.76(2.38-5.96)	12.049	0.001
	N	275/366	3.29(1.95-5.31)
Risk factor score	0	134/180	2.77(1.61-4.29)	27.29	0
	1	170/220	3.15(2.02-5.03)
	2	123/151	3.97(2.39-6.03)
	3	56/65	4.56(3.04-7.19)
	4	29/27	6.18(3.83-11.39)
	≥5	18/15	6.89(4.45-12.30)

M/F, male/female; Y or N, presence or absence of risk factors.